Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery

Bibliography

• Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation 2012;125:e2-e220
   PubMed Web of Science ®Google Scholar
• Beckmann BM, Wilde AA, Kaab S. Clinical utility gene card for: long-QT syndrome (types 1-13). Eur J Hum Genet 2013;21: doi:10.1038/ejhg.2013.28
   PubMed Web of Science ®Google Scholar
• Berne P, Brugada J. Brugada syndrome 2012. Circ J 2012;76:1563-71
   PubMed Web of Science ®Google Scholar
• Napolitano C, Bloise R, Memmi M, et al. Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT). Eur J Hum Genet 2013:e1-e3 doi:10.1038/ejhg.2013.55
   Google Scholar
• Napolitano C, Bloise R, Monteforte N, et al. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation. Circulation 2012;125:2027-34
   PubMed Web of Science ®Google Scholar
• Patel C, Yan GX, Antzelevitch C. Short QT syndrome: from bench to bedside. Circ Arrhythm Electrophysiol 2010;3:401-8
   PubMed Web of Science ®Google Scholar
• Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation 2009;120:1761-7
   PubMed Web of Science ®Google Scholar
• Curran ME, Splawski I, Timothy KW, et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80:795-803
   PubMed Web of Science ®Google Scholar
• Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996;12:17-23
   PubMed Web of Science ®Google Scholar
• Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80:805-11
   PubMed Web of Science ®Google Scholar
• Watanabe H, Yang T, Stroud DM, et al. Striking in vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Circulation 2011;124:1001-11
   PubMed Web of Science ®Google Scholar
• Kaese S, Verheule S. Cardiac electrophysiology in mice: a matter of size. Front Physiol 2012;3:345
   Google Scholar
• Roden DM, Altman RB, Benowitz NL, et al. Pharmacogenomics: challenges and opportunities. Ann Intern Med 2006;145:749-57
   PubMed Web of Science ®Google Scholar
• MacRae CA. Recent advances in in vivo screening for antiarrhythmic drugs. Expert Opin Drug Discov 2013;8:131-41
   PubMed Web of Science ®Google Scholar
• Verkerk AO, Remme CA. Zebrafish: a novel research tool for cardiac (patho)electrophysiology and ion channel disorders. Front Physiol 2012;3:255
   PubMed Web of Science ®Google Scholar
• Pammolli F, Magazzini L, Riccaboni M. The productivity crisis in pharmaceutical R&D. Nat Rev Drug Discov 2011;10:428-38
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76
   PubMed Web of Science ®Google Scholar
• Grskovic M, Javaherian A, Strulovici B, Daley GQ. Induced pluripotent stem cells-opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 2011;10:915-29
   PubMed Web of Science ®Google Scholar
• Rudy Y, Ackerman MJ, Bers DM, et al. Systems approach to understanding electromechanical activity in the human heart: a national heart, lung, and blood institute workshop summary. Circulation 2008;118:1202-11
   PubMed Web of Science ®Google Scholar
• Abriel H, Zaklyazminskaya EV. Cardiac channelopathies: genetic and molecular mechanisms. Gene 2013;517:1-11
   PubMed Web of Science ®Google Scholar
• Antzelevitch C, Pollevick GD, Cordeiro JM, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007;115:442-9
   PubMed Web of Science ®Google Scholar
• van der Werf C, Wilde AA. Catecholaminergic polymorphic ventricular tachycardia: from bench to bedside. Heart 2013;99:497-504
   PubMed Web of Science ®Google Scholar
• Darbar D, Roden DM. Genetic mechanisms of atrial fibrillation: impact on response to treatment. Nat Rev Cardiol 2013;10:317-29
   PubMed Web of Science ®Google Scholar
• OMIM - Online Mendelian Inheritance in Man: An Online Catalog of Human Genes and Genetic Disorders. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA, 1966-2013. Available from: http://www.omim.org/ Last accessed 1 October 2013]
   Google Scholar
• Kattygnarath D, Maugenre S, Neyroud N, et al. MOG1: a new susceptibility gene for Brugada syndrome. Circ Cardiovasc Genet 2011;4:261-8
   PubMed Web of Science ®Google Scholar
• Hsiao PY, Tien HC, Lo CP, et al. Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies. Appl Clin Genet 2013;6:1-13
   Google Scholar
• Savio-Galimberti E, Gollob MH, Darbar D. Voltage-gated sodium channels: biophysics, pharmacology, and related channelopathies. Front Pharmacol 2012;3:124
   PubMed Web of Science ®Google Scholar
• Amin AS, Asghari-Roodsari A, Tan HL. Cardiac sodium channelopathies. Pflugers Arch 2010;460:223-37
   PubMed Web of Science ®Google Scholar
• Makita N, Behr E, Shimizu W, et al. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest 2008;118:2219-29
   PubMed Web of Science ®Google Scholar
• Shimizu W, Horie M. Phenotypic manifestations of mutations in genes encoding subunits of cardiac potassium channels. Circ Res 2011;109:97-109
   PubMed Web of Science ®Google Scholar
• Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol 2012;5:868-77
   PubMed Web of Science ®Google Scholar
• Gurdon JB. From nuclear transfer to nuclear reprogramming: the reversal of cell differentiation. Annu Rev Cell Dev Biol 2006;22:1-22
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72
   PubMed Web of Science ®Google Scholar
• Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-20
   PubMed Web of Science ®Google Scholar
• Okita K, Yamakawa T, Matsumura Y, et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 2013;31:458-66
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li W, Laurent T, et al. Small molecules, big roles - the chemical manipulation of stem cell fate and somatic cell reprogramming. J Cell Sci 2012;125:5609-20
   PubMed Web of Science ®Google Scholar
• Hou P, Li Y, Zhang X, et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013;341:651-4
   PubMed Web of Science ®Google Scholar
• Rais Y, Zviran A, Geula S, et al. Deterministic direct reprogramming of somatic cells to pluripotency. Nature 2013;502(7469):65-70
   PubMed Web of Science ®Google Scholar
• Aasen T, Raya A, Barrero MJ, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008;26:1276-84
   PubMed Web of Science ®Google Scholar
• Kim JB, Sebastiano V, Wu G, et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009;136:411-19
   PubMed Web of Science ®Google Scholar
• Zhou T, Benda C, Duzinger S, et al. Generation of induced pluripotent stem cells from urine. J Am Soc Nephrol 2011;22:1221-8
   PubMed Web of Science ®Google Scholar
• Dowey SN, Huang X, Chou BK, et al. Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression. Nat Protoc 2012;7:2013-21
   PubMed Web of Science ®Google Scholar
• Narsinh KH, Jia F, Robbins RC, et al. Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc 2011;6:78-88
   Google Scholar
• Okita K, Matsumura Y, Sato Y, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 2011;8:409-12
   PubMed Web of Science ®Google Scholar
• Mandal PK, Rossi DJ. Reprogramming human fibroblasts to pluripotency using modified mRNA. Nat Protoc 2013;8:568-82
   PubMed Web of Science ®Google Scholar
• Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009;4:472-6
   PubMed Web of Science ®Google Scholar
• Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009;4:381-4
   PubMed Web of Science ®Google Scholar
• Beers J, Gulbranson DR, George N, et al. Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions. Nat Protoc 2012;7:2029-40
   PubMed Web of Science ®Google Scholar
• Chen G, Gulbranson DR, Hou Z, et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods 2011;8:424-9
   PubMed Web of Science ®Google Scholar
• Ding Q, Lee YK, Schaefer EA, et al. A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell 2013;12:238-51
   PubMed Web of Science ®Google Scholar
• Mummery CL, Zhang J, Ng ES, et al. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res 2012;111:344-58
   PubMed Web of Science ®Google Scholar
• Verma V, Purnamawati K, Manasi et al. Steering signal transduction pathway towards cardiac lineage from human pluripotent stem cells: a review. Cell Signal 2013;25:1096-107
   PubMed Web of Science ®Google Scholar
• Xu C. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells. J Mol Cell Cardiol 2012;52:1203-12
   PubMed Web of Science ®Google Scholar
• Robertson C, Tran DD, George SC. Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells 2013;31:829-37
   PubMed Web of Science ®Google Scholar
• Yu T, Miyagawa S, Miki K, et al. In vivo differentiation of induced pluripotent stem cell-derived cardiomyocytes. Circ J 2013;77:1297-306
   PubMed Web of Science ®Google Scholar
• Gherghiceanu M, Barad L, Novak A, et al. Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure. J Cell Mol Med 2011;15:2539-51
   PubMed Web of Science ®Google Scholar
• Novak A, Barad L, Zeevi-Levin N, et al. Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to beta-adrenergic stimulation. J Cell Mol Med 2012;16:468-82
   PubMed Web of Science ®Google Scholar
• Lieu DK, Liu J, Siu CW, et al. Absence of transverse tubules contributes to non-uniform Ca2+ wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes. Stem Cells Dev 2009;18:1493-500
   PubMed Web of Science ®Google Scholar
• Nunes SS, Miklas JW, Liu J, et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods 2013;10:781-7
   PubMed Web of Science ®Google Scholar
• Lee P, Klos M, Bollensdorff C, et al. Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell-derived cardiac myocyte monolayers. Circ Res 2012;110:1556-63
   PubMed Web of Science ®Google Scholar
• Gupta MK, Illich DJ, Gaarz A, et al. Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar. BMC Dev Biol 2010;10:98
   PubMed Web of Science ®Google Scholar
• Zhang J, Wilson GF, Soerens AG, et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009;104:e30-41
   PubMed Web of Science ®Google Scholar
• Streckfuss-Bomeke K, Wolf F, Azizian A, et al. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Eur Heart J 2013;34:2618-29
   PubMed Web of Science ®Google Scholar
• Mummery C, Ward-van Oostwaard D, Doevendans P, et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003;107:2733-40
   PubMed Web of Science ®Google Scholar
• He JQ, Ma Y, Lee Y, et al. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003;93:32-9
   PubMed Web of Science ®Google Scholar
• Ma J, Guo L, Fiene SJ, et al. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am J Physiol Heart Circ Physiol 2011;301:H2006-17
   PubMed Web of Science ®Google Scholar
• Lieu DK, Fu JD, Chiamvimonvat N, et al. Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Arrhythm Electrophysiol 2013;6:191-201
   PubMed Web of Science ®Google Scholar
• Lee YK, Ng KM, Lai WH, et al. Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Rev 2011;7:976-86
   PubMed Web of Science ®Google Scholar
• Pekkanen-Mattila M, Chapman H, Kerkela E, et al. Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype. Exp Biol Med (Maywood) 2010;235:522-30
   PubMed Web of Science ®Google Scholar
• Zhang Q, Jiang J, Han P, et al. Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res 2011;21:579-87
   PubMed Web of Science ®Google Scholar
• Doss MX, Di Diego JM, Goodrow RJ, et al. Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on I(Kr). PLoS ONE 2012;7:e40288
   PubMed Web of Science ®Google Scholar
• Cordeiro JM, Nesterenko VV, Sicouri S, et al. Identification and characterization of a transient outward K+ current in human induced pluripotent stem cell-derived cardiomyocytes. J Mol Cell Cardiol 2013;60:36-46
   PubMed Web of Science ®Google Scholar
• Ivashchenko CY, Pipes GC, Lozinskaya IM, et al. Human induced pluripotent stem cell derived cardiomyocytes exhibit temporal changes in phenotype. Am J Physiol Heart Circ Physiol 2013;305(6):H913-22
   PubMed Web of Science ®Google Scholar
• Jonsson MK, Vos MA, Mirams GR, et al. Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG. J Mol Cell Cardiol 2012;52:998-1008
   PubMed Web of Science ®Google Scholar
• Zhang YM, Hartzell C, Narlow M, et al. Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. Circulation 2002;106:1294-9
   PubMed Web of Science ®Google Scholar
• Davis RP, Casini S, van den Berg CW, et al. Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation 2012;125:3079-91
   PubMed Web of Science ®Google Scholar
• Shinozawa T, Imahashi K, Sawada H, et al. Determination of appropriate stage of human-induced pluripotent stem cell-derived cardiomyocytes for drug screening and pharmacological evaluation in vitro. J Biomol Screen 2012;17:1192-203
   PubMed Web of Science ®Google Scholar
• Drouin E, Charpentier F, Gauthier C, et al. Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J Am Coll Cardiol 1995;26:185-92
   PubMed Web of Science ®Google Scholar
• Honda M, Kiyokawa J, Tabo M, et al. Electrophysiological characterization of cardiomyocytes derived from human induced pluripotent stem cells. J Pharmacol Sci 2011;117:149-59
   PubMed Web of Science ®Google Scholar
• Kim C, Majdi M, Xia P, et al. Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. Stem Cells Dev 2010;19:783-95
   PubMed Web of Science ®Google Scholar
• Liu J, Fu JD, Siu CW, et al. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 2007;25:3038-44
   PubMed Web of Science ®Google Scholar
• Itzhaki I, Rapoport S, Huber I, et al. Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS One 2011;6:e18037
   PubMed Web of Science ®Google Scholar
• Zhang XH, Haviland S, Wei H, et al. Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects. Cell Calcium 2013;54:57-70
   PubMed Web of Science ®Google Scholar
• Mehta A, Chung YY, Ng A, et al. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells. Cardiovasc Res 2011;91:577-86
   PubMed Web of Science ®Google Scholar
• Germanguz I, Sedan O, Zeevi-Levin N, et al. Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. J Cell Mol Med 2011;15:38-51
   PubMed Web of Science ®Google Scholar
• He LP, Cleemann L, Soldatov NM, et al. Molecular determinants of cAMP-mediated regulation of the Na+-Ca2+ exchanger expressed in human cell lines. J Physiol 2003;548:677-89
   PubMed Web of Science ®Google Scholar
• Zhang GQ, Wei H, Lu J, et al. Identification and characterization of calcium sparks in cardiomyocytes derived from human induced pluripotent stem cells. PLoS ONE 2013;8:e55266
   PubMedGoogle Scholar
• Lundy SD, Zhu WZ, Regnier M, et al. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev 2013;22:1991-2002
   PubMed Web of Science ®Google Scholar
• Rao C, Prodromakis T, Kolker L, et al. The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials 2013;34:2399-411
   PubMed Web of Science ®Google Scholar
• Li S, Chen G, Li RA. Calcium signaling of human pluripotent stem cell-derived cardiomyocytes. J Physiol 2013;591(Pt 21):5279-90
   PubMed Web of Science ®Google Scholar
• Dick E, Rajamohan D, Ronksley J, et al. Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. Biochem Soc Trans 2010;38:1037-45
   PubMed Web of Science ®Google Scholar
• Gai H, Leung EL, Costantino PD, et al. Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts. Cell Biol Int 2009;33:1184-93
   PubMedGoogle Scholar
• Sequiera GL, Mehta A, Ooi TH, et al. Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart. Life Sci 2013;92:63-71
   PubMed Web of Science ®Google Scholar
• Mehta A, Chung Y, Sequiera GL, et al. Pharmacoelectrophysiology of viral-free induced pluripotent stem cell-derived human cardiomyocytes. Toxicol Sci 2013;131:458-69
   PubMed Web of Science ®Google Scholar
• Yokoo N, Baba S, Kaichi S, et al. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem Biophys Res Commun 2009;387:482-8
   PubMed Web of Science ®Google Scholar
• Braam SR, Tertoolen L, van de Stolpe A, et al. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 2010;4:107-16
   PubMed Web of Science ®Google Scholar
• Liang P, Lan F, Lee AS, et al. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation 2013;127:1677-91
   PubMed Web of Science ®Google Scholar
• Guo L, Qian JY, Abrams R, et al. The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts. Cell Physiol Biochem 2011;27:453-62
   PubMed Web of Science ®Google Scholar
• Braam SR, Tertoolen L, Casini S, et al. Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes. Stem Cell Res 2013;10:48-56
   PubMed Web of Science ®Google Scholar
• Moretti A, Bellin M, Welling A, et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010;363:1397-409
   PubMed Web of Science ®Google Scholar
• Egashira T, Yuasa S, Suzuki T, et al. Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovasc Res 2012;95:419-29
   PubMed Web of Science ®Google Scholar
• Itzhaki I, Maizels L, Huber I, et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011;471:225-9
   PubMed Web of Science ®Google Scholar
• Matsa E, Rajamohan D, Dick E, et al. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. Eur Heart J 2011;32:952-62
   PubMed Web of Science ®Google Scholar
• Lahti AL, Kujala VJ, Chapman H, et al. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis Model Mech 2012;5:220-30
   PubMed Web of Science ®Google Scholar
• Terrenoire C, Wang K, Tung KW, et al. Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. J Gen Physiol 2013;141:61-72
   PubMed Web of Science ®Google Scholar
• Yazawa M, Hsueh B, Jia X, et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 2011;471:230-4
   PubMed Web of Science ®Google Scholar
• Fatima A, Xu G, Shao K, et al. In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells. Cell Physiol Biochem 2011;28:579-92
   PubMed Web of Science ®Google Scholar
• Itzhaki I, Maizels L, Huber I, et al. Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. J Am Coll Cardiol 2012;60:990-1000
   PubMed Web of Science ®Google Scholar
• Jung CB, Moretti A, Mederos y Schnitzler M, et al. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol Med 2012;4:180-91
   PubMed Web of Science ®Google Scholar
• Kujala K, Paavola J, Lahti A, et al. Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations. PLoS ONE 2012;7:e44660
   PubMed Web of Science ®Google Scholar
• Nakajima T, Furukawa T, Tanaka T, et al. Novel mechanism of HERG current suppression in LQT2: shift in voltage dependence of HERG inactivation. Circ Res 1998;83:415-22
   PubMed Web of Science ®Google Scholar
• Venetucci L, Denegri M, Napolitano C, et al. Inherited calcium channelopathies in the pathophysiology of arrhythmias. Nat Rev Cardiol 2012;9:561-75
   PubMed Web of Science ®Google Scholar
• Jiang D, Xiao B, Yang D, et al. RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). Proc Natl Acad Sci USA 2004;101:13062-7
   PubMed Web of Science ®Google Scholar
• Kashimura T, Briston SJ, Trafford AW, et al. In the RyR2(R4496C) mouse model of CPVT, beta-adrenergic stimulation induces Ca waves by increasing SR Ca2+ content and not by decreasing the threshold for Ca2+ waves. Circ Res 2010;107:1483-9
   PubMed Web of Science ®Google Scholar
• Rizzi N, Liu N, Napolitano C, et al. Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model. Circ Res 2008;103:298-306
   PubMed Web of Science ®Google Scholar
• Soto-Gutierrez A, Wertheim JA, Ott HC, et al. Perspectives on whole-organ assembly: moving toward transplantation on demand. J Clin Invest 2012;122:3817-23
   PubMed Web of Science ®Google Scholar
• Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008;14:213-21
   PubMed Web of Science ®Google Scholar